LIVN Q2 2021 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$264M+45.2% YoY

Gross Profit

$172M65.1% margin

Operating Income

-$36M-13.7% margin

Net Income

-$56M-21.4% margin

EPS (Diluted)

$-1.13

QoQ Revenue Growth

+6.8%

Cash Flow

Operating Cash Flow

$25M

Free Cash Flow

$19M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.4B

Stockholders' Equity

$1.0B

Cash & Equivalents

$329M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$264M	$182M	+45.2%
Gross Profit	$172M	$116M	+47.9%
Operating Income	-$36M	-$15M	-138.0%
Net Income	-$56M	-$88M	+35.8%

Revenue Segments

Cardiovascular Segment

$146M55%

Neuromodulation Segment

$118M45%

Geographic Segments

UNITED STATES

$144M55%

Locations Excluding The United States And Europe

$64M24%

Europe

$56M21%